Xifeng Wu

Xifeng Wu () is a Chinese-American cancer epidemiologist known for her cohort studies designed to discover the causes of cancer. She has been Dean of the School of Public Health of Zhejiang University since March 2019. She previously served as Director of the Center for Public Health and Translational Genomics and the Betty B. Marcus Chair in Cancer Prevention at the University of Texas MD Anderson Cancer Center until she was forced to resign in January 2019, as part of the Trump administration's push to counter Chinese influence in American research according to Bloomberg Businessweek. Provided by Wikipedia
Showing 1 - 4 results of 4 for search 'Wu, Xifeng', query time: 0.03s Refine Results
  1. 1
    Risk of urinary bladder cancer: a case-control analysis of industry and occupation

    Risk of urinary bladder cancer: a case-control analysis of industry and occupation by Wu Xifeng, Wang Wei, Cassidy Adrian, Lin Jie

    Published 2009-12-01
    Get full text
    Article
  2. 2
    Mobile Phone Use and its Association With Sitting Time and Meeting Physical Activity Recommendations in a Mexican American Cohort

    Mobile Phone Use and its Association With Sitting Time and Meeting Physical Activity Recommendations in a Mexican American Cohort by Chrisman, Matthew, Chow, Wong-Ho, Daniel, Carrie R, Wu, Xifeng, Zhao, Hua

    Published 2016-06-01
    Get full text
    Article
  3. 3
    Genetic variation in DNA-repair pathways and response to radiochemotherapy in esophageal adenocarcinoma: a retrospective cohort study of the Eastern Cooperative Oncology Group

    Genetic variation in DNA-repair pathways and response to radiochemotherapy in esophageal adenocarcinoma: a retrospective cohort study of the Eastern Cooperative Oncology Group by Wu Xifeng, Meltzer Stephen J, Liu Geoffrey, Offer Steven M, Hafez Michael J, Montgomery Elizabeth A, Powell Mark, Philips Santosh, Skaar Todd C, Murphy Kathleen M, Catalano Paul J, Yoon Harry H, Forastiere Arlene A, Benson Al B, Kleinberg Lawrence R, Gibson Michael K

    Published 2011-05-01
    Get full text
    Article
  4. 4
    A systematic approach to biomarker discovery; Preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers"

    A systematic approach to biomarker discovery; Preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers" by Schendel Dolores, Rivoltini Licia, Ribas Antoni, Potter Douglas M, Palucka A Karolina, Masucci Giuseppe, Malyguine Anatoli, Maecker Holden, Maio Michele, Maccalli Cristina, Kirkwood John M, Kleen Thomas O, Janetzki Sylvia, Håkansson Leif, Dhodapkar Madhav, Coukos George, Chaussabel Damien, Wigginton Jon, Wang Ena, Trinchieri Giorgio, Thurin Magdalena, Khleif Samir N, Lee Peter P, Fox Bernard A, Disis Mary L, Butterfield Lisa H, Seliger Barbara, Selvan Senthamil, Slingluff Craig L, Stroncek David F, Streicher Howard, Wu Xifeng, Zeskind Benjamin, Zhao Yingdong, Zocca Mai-Britt, Zwierzina Heinz, Marincola Francesco M

    Published 2008-12-01
    Get full text
    Article

Search Tools: